North Korea vs South Asia: Immunization, Hib3
North Korea
99.0%
in 2024
South Asia
94.5%
in 2024
North Korea rank
1st
South Asia rank
1st
Immunization, Hib3 over time
- North Korea
- South Asia
How they compare
North Korea currently reports 99.0% against 94.5% in South Asia, a difference of 4.5%.
Across all 13 years both countries report, North Korea has been ahead every year.
North Korea ranks 1st and South Asia ranks 1st of 191 countries.
North Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Korea | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 87.6% | 60.2% | 27.4% | North Korea |
| 2020s | 98.6% | 90.6% | 8.0% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, North Korea or South Asia?
- North Korea, at 99.0% against 94.5% in South Asia as of 2024.
- What is the difference in immunization, hib3 between North Korea and South Asia?
- 4.5%, with North Korea ahead.
- How many years of comparable data are there for North Korea and South Asia?
- 13 years are reported by both, from 2012 to 2024.
- How do North Korea and South Asia rank globally for immunization, hib3?
- North Korea ranks 1st and South Asia ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.